Hiroki Tsukamoto
Overview
Explore the profile of Hiroki Tsukamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phan H, Yasuda S, Oba K, Tsukamoto H, Hori T, Kuroiwa M, et al.
ISME J
. 2025 Feb;
19(1).
PMID: 39913347
Shifting from ammonia removal to recovery is the current strategy in wastewater treatment management. We recently developed a microaerophilic activated sludge system for retaining ammonia whereas removing organic carbon with...
2.
Kobayashi Y, Sato R, Shimizu Y, Fukui R, Shibata T, Tsukamoto H, et al.
Int Immunol
. 2025 Jan;
PMID: 39868594
The cancer driver mutation L265P MyD88 is found in approximately 30 % of cases in the activated B cell-like subgroup of diffuse large B cell-like lymphoma (ABC DLBCL). L265P MyD88...
3.
Duan J, Kitamura K, Tsukamoto H, Van Phan H, Oba K, Hori T, et al.
Water Res
. 2024 Jan;
251:121091.
PMID: 38244299
Ammonia retention and recovery from high-nitrogenous wastewater are new concepts being used for nitrogen management. A microaerophilic activated sludge system was developed to convert organic nitrogen into ammonia and retain...
4.
Tsukamoto H, Phan H, Suenaga T, Yasuda S, Kuroiwa M, Riya S, et al.
Environ Sci Technol
. 2023 Sep;
57(37):13874-13886.
PMID: 37676844
A transition to ammonia recovery from wastewater has started; however, a technology for sustainable nitrogen retention in the form of ammonia and organic carbon removal is still in development. This...
5.
Liu H, Ikeda K, Nguyen M, Sato S, Matsuda N, Tsukamoto H, et al.
ACS Omega
. 2022 Feb;
7(7):6238-6247.
PMID: 35224386
A one-step preparation of alginate-stabilized gold nanoparticles (Au NPs) using the microwave-induced plasma-in-liquid process (MWPLP) was reported. Effects of alginate with various concentrations on the preparation and properties of the...
6.
Locker K, Kachapati K, Wu Y, Bednar K, Adams D, Patel C, et al.
Diabetes
. 2022 Jan;
71(3):470-482.
PMID: 35040474
We previously showed that treating NOD mice with an agonistic monoclonal anti-TLR4/MD2 antibody (TLR4-Ab) reversed acute type 1 diabetes (T1D). Here, we show that TLR4-Ab reverses T1D by induction of...
7.
Sato R, Reuter T, Hiranuma R, Shibata T, Fukui R, Motoi Y, et al.
Int Immunol
. 2020 Aug;
32(12):785-798.
PMID: 32840578
Toll-like receptors (TLRs) impact myeloid cell responsiveness to environmental cues such as pathogen components and metabolites. Although TLR protein expression in monocytes and tissue macrophages is thought to be optimized...
8.
Kanemitsu Y, Mishima E, Maekawa M, Matsumoto Y, Saigusa D, Yamaguchi H, et al.
Sci Rep
. 2019 Dec;
9(1):19075.
PMID: 31836785
Carboxyl-containing metabolites, such as bile acids and fatty acids, have many important functions and microbiota is involved in the production of them. In the previous study, we found that the...
9.
Tsukamoto H, Kubota K, Shichiku A, Maekawa M, Mano N, Yagita H, et al.
Immunology
. 2019 Sep;
158(2):136-149.
PMID: 31515801
Immune-checkpoint blockade antibodies have been approved for the treatment of cancer. However, poorly immunogenic tumours are less responsive to such therapies. Agonistic anti-Toll-like receptor 4 (TLR4) monoclonal antibodies (mAbs) activate...
10.
Ishida Y, Motono S, Doshin W, Tokunaga T, Tsukamoto H, Yonezawa T
ACS Omega
. 2019 Aug;
2(8):5104-5110.
PMID: 31457785
Production of oxygen-deficient tungsten oxide nanoparticles with a diameter of around 10 nm have been successfully developed using a microwave-induced plasma in liquid technique. The prepared blue-green nanoparticles exhibit strong...